Amanote Research

Amanote Research

    RegisterSign In

Emerging Drugs for Duchenne Muscular Dystrophy

Expert Opinion on Emerging Drugs - United Kingdom
doi 10.1517/14728214.2012.691965
Full Text
Open PDF
Abstract

Available in full text

Categories
Pharmacology
Date

May 25, 2012

Authors
Vinod MalikLouise R. Rodino-KlapacJerry R Mendell
Publisher

Informa Healthcare


Related search

Mesenchymal Stem Cells: Emerging Therapy for Duchenne Muscular Dystrophy

PM and R
Physical TherapySports ScienceSports TherapyNeurologyMedicineRehabilitation
2009English

Duchenne Muscular Dystrophy

Physiotherapy
Physical TherapySports TherapyRehabilitation
1990English

Duchenne Muscular Dystrophy

English

Duchenne Muscular Dystrophy

Methods in Molecular Biology
GeneticsMolecular Biology
2018English

Duchenne Muscular Dystrophy

2020English

Emerging Strategies in the Treatment of Duchenne Muscular Dystrophy

Neurotherapeutics
NeurologyPharmacology
2018English

Gene Therapy for Duchenne Muscular Dystrophy

Archives of Neurology
2007English

150. Ex Vivo Gene Therapy of Duchenne Muscular Dystrophy Using iPSCs From Duchenne Muscular Dystrophy Patients

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2014English

Genome Editing Gene Therapy for Duchenne Muscular Dystrophy

Journal of Neuromuscular Diseases
Neurology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy